Simonetta Chiara Stani

493 total citations
23 papers, 316 citations indexed

About

Simonetta Chiara Stani is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, Simonetta Chiara Stani has authored 23 papers receiving a total of 316 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Oncology, 11 papers in Pulmonary and Respiratory Medicine and 7 papers in Cancer Research. Recurrent topics in Simonetta Chiara Stani's work include Cancer Treatment and Pharmacology (6 papers), Breast Cancer Treatment Studies (5 papers) and HER2/EGFR in Cancer Research (5 papers). Simonetta Chiara Stani is often cited by papers focused on Cancer Treatment and Pharmacology (6 papers), Breast Cancer Treatment Studies (5 papers) and HER2/EGFR in Cancer Research (5 papers). Simonetta Chiara Stani collaborates with scholars based in Italy, United Kingdom and France. Simonetta Chiara Stani's co-authors include Emilio Bajetta, Luigi Mariani, Paolo Bidoli, Nicoletta Zilembo, Paola Pozzi, Federico Bozzetti, Luigi Celio, Alfonso Marchianò, L Guillevin and Mitch Dowsett and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and Cancer Research.

In The Last Decade

Simonetta Chiara Stani

22 papers receiving 305 citations

Peers

Simonetta Chiara Stani
George Pavlakis Greece
Antonio Manganelli Italy
Evangelos Chandanos Sweden
Kazuaki Machioka Japan
Maria Teresa Ionta Italy
Ragnhild Klepp Norway
Arturo Mendoza-Valdés Mexico
RJ Prescott United Kingdom
Fred Saad Canada
Shuai Hu China
George Pavlakis Greece
Simonetta Chiara Stani
Citations per year, relative to Simonetta Chiara Stani Simonetta Chiara Stani (= 1×) peers George Pavlakis

Countries citing papers authored by Simonetta Chiara Stani

Since Specialization
Citations

This map shows the geographic impact of Simonetta Chiara Stani's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Simonetta Chiara Stani with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Simonetta Chiara Stani more than expected).

Fields of papers citing papers by Simonetta Chiara Stani

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Simonetta Chiara Stani. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Simonetta Chiara Stani. The network helps show where Simonetta Chiara Stani may publish in the future.

Co-authorship network of co-authors of Simonetta Chiara Stani

This figure shows the co-authorship network connecting the top 25 collaborators of Simonetta Chiara Stani. A scholar is included among the top collaborators of Simonetta Chiara Stani based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Simonetta Chiara Stani. Simonetta Chiara Stani is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Cona, Maria Silvia, Lorenzo Ruggieri, Salvatore Artale, et al.. (2024). 390P SARELIFE: An Italian, multicentric real-world study of sacituzumab govitecan (SG) in pretreated metastatic triple-negative breast cancer (mTNBC). Annals of Oncology. 35. S381–S382. 1 indexed citations
2.
Fabi, Alessandra, Katia Cannita, G. Ferretti, et al.. (2016). Real-life effectiveness of T-DM1 in heavily pretreated HER2-positive advanced breast cancer patients: An Italian observational study.. Journal of Clinical Oncology. 34(15_suppl). e12019–e12019. 1 indexed citations
3.
Gasparini, Giampietro, Simonetta Chiara Stani, Luigi Mariani, et al.. (2005). The Combination of the Selective Cyclooxygenase-2 Inhibitor Celecoxib with Weekly Paclitaxel Is a Safe and Active Second-Line Therapy for Non-Small Cell Lung Cancer. The Cancer Journal. 11(3). 209–216. 28 indexed citations
4.
Morabito, Alessandro, Domenico Gattuso, Simonetta Chiara Stani, et al.. (2004). Safety and Activity of the Combination of Pegylated Liposomal Doxorubicin and Weekly Docetaxel in Advanced Breast Cancer. Breast Cancer Research and Treatment. 86(3). 249–258. 24 indexed citations
5.
Stani, Simonetta Chiara, Guido Carillio, Alessandro Morabito, et al.. (2004). Phase II study of celecoxib and weekly paclitaxel in the treatment of pretreated advanced non-small cell lung cancer (NSCLC). Journal of Clinical Oncology. 22(14_suppl). 7337–7337. 4 indexed citations
6.
Morabito, Alessandro, Guido Carillio, Raffaele Longo, et al.. (2004). Gemcitabine, vinorelbine and trastuzumab combination (GemVinT) as second-third line therapy for HER-2 overexpressing metastatic breast cancer (MBC). Journal of Clinical Oncology. 22(14_suppl). 759–759. 12 indexed citations
7.
Bajetta, Emilio, Simonetta Chiara Stani, Nadia Zaffaroni, et al.. (2003). Preclinical and clinical evaluation of four gemcitabine plus carboplatin schedules as front-line treatment for stage IVnon-small-cell lung cancer. Annals of Oncology. 14(2). 242–247. 15 indexed citations
8.
9.
Stani, Simonetta Chiara, Roberta Sarmiento, Giovanni Mansueto, et al.. (2003). Second line treatment of antiangiogenic therapy with celecoxib and weekly paclitaxel for advanced non-small cell lung cancer (NSCLC). Lung Cancer. 41. S181–S181. 1 indexed citations
10.
Stani, Simonetta Chiara, et al.. (2003). . American Journal of Clinical Oncology. 26(3). 265–269. 1 indexed citations
11.
Stani, Simonetta Chiara, et al.. (2002). Antiangiogenic agents.. PubMed. 1(4). S39–43. 1 indexed citations
12.
Bozzetti, Federico, Salvatore Andreola, Dario Baratti, et al.. (2002). Preoperative chemoradiation in patients with resectable rectal cancer: Results on tumor response. Annals of Surgical Oncology. 9(5). 444–449. 26 indexed citations
13.
Bidoli, Paolo, Emilio Bajetta, Simonetta Chiara Stani, et al.. (2002). Ten‐year survival with chemotherapy and radiotherapy in patients with squamous cell carcinoma of the esophagus. Cancer. 94(2). 352–361. 34 indexed citations
14.
Bidoli, Paolo, et al.. (2001). Single-Agent Chemotherapy with Vinorelbine for Pretreated or Metastatic Squamous Cell Carcinoma of the Esophagus. Tumori Journal. 87(5). 299–302. 13 indexed citations
15.
Martinetti, Antonia, Emilio Bajetta, Roberto Buzzoni, et al.. (2001). Biological study of anastrozole in post-menopausal advanced breast cancer (ABC) patients: Effects on bone metabolism and oestrogen suppression. European Journal of Cancer. 37. S197–S197. 1 indexed citations
16.
Stani, Simonetta Chiara, Emilio Bajetta, Paola Pozzi, et al.. (2001). Front line chemotherapy with four different schedules of gemcitabine and carboplatin in stage IV non-small cell lung cancer (NSCLC). European Journal of Cancer. 37. S55–S55. 3 indexed citations
17.
Bajetta, Emilio, Simonetta Chiara Stani, Paolo Bidoli, et al.. (2000). Gemcitabine plus vinorelbine as first-line chemotherapy in advanced nonsmall cell lung carcinoma a Phase II trial. Cancer. 89(4). 763–768. 24 indexed citations
18.
Bajetta, Emilio, E. Bichisao, Salvatore Artale, et al.. (2000). New clinical trials for the treatment of neuroendocrine tumors.. PubMed. 44(1). 96–101. 5 indexed citations
19.
Bajetta, Emilio, Maria Di Bartolomeo, Simonetta Chiara Stani, et al.. (1999). Chemoradiotherapy as preoperative treatment in locally advanced unresectable pancreatic cancer patients: results of a feasibility study11Data management by Italian Trials in Medical Oncology (I.T.M.O.) Scientific Service.. International Journal of Radiation Oncology*Biology*Physics. 45(2). 285–289. 43 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by George Pavlakis Breakdown of academic impact, for papers by Antonio Manganelli Breakdown of academic impact, for papers by Evangelos Chandanos Breakdown of academic impact, for papers by Kazuaki Machioka Breakdown of academic impact, for papers by Maria Teresa Ionta Breakdown of academic impact, for papers by Ragnhild Klepp Breakdown of academic impact, for papers by Arturo Mendoza-Valdés Breakdown of academic impact, for papers by RJ Prescott Breakdown of academic impact, for papers by Fred Saad Breakdown of academic impact, for papers by Shuai Hu
Rankless by CCL
2026